Custom tombstone marking the acquisition of Israeli firm Prolor Biotech. The acquiring company was Miami-based pharmaceutical and biotechnology firm Opko Health.
Whether you’re celebrating a funding round, research collaboration, FDA-approval, or commemorating a deal in the biotech space, you’ll find inspiration in the custom designs below.
Custom tombstone marking the acquisition of Israeli firm Prolor Biotech. The acquiring company was Miami-based pharmaceutical and biotechnology firm Opko Health.
Lucite deal toy recognizing two stock offerings by Oxygen Biotherapuetics. The specialty pharmaceutical firm, now known as Tenax Therapeutics, is based in Morrisville, North Carolina.
(3ASH0BF)Financial tombstone recognizing the private placement of shares in Bionor Pharma. Headquartered in Oslo, Norway, the firm specializes in vaccines aimed at rapidly mutating virus infections such as HIV and Influenza.
Custom biotech acquisition deal toy recognizing the acquisition of BioBehavioral Diagnostics Company (BioBDX). The firm was acquired by educational and business publisher Pearson.
Job:Â 3AJS09D
Beginning on this page, you’ll find galleries with over 90 images of financial tombstones and deal toys from the biotech and life sciences space. You’ll find a number of custom designs playing off visual elements commonly associated with this space, including DNA strands, pills, lab beakers, periodic tables, as well as ones incorporating actual drug vials.
As you might also expect, you’ll see a number of deal toys involving internationally recognized firms and players. These include Takeda Pharmaceutical, Horizon Therapeutics, Gilead Sciences, Roche, Neurocrine, and Bayer. You’ll see as well tombstones commemorating transactions common to this sector involving these and other firms: joint ventures, licensing deals, and development and commercialization agreements.
But you’ll also notice a number of deals commemorated here that may involve far less familiar firms. These include the acquisition of a Dutch company focused on live-cell imaging analytics, and one of an Illinois-based gene therapy firm devoted to the treatment of a rare genetic disorder; the initial public offering of an Australian developer of radiopharmaceutical cancer therapies, and the IPO of a Norwegian biotech making use of marine compounds such as herring roe extract; early-stage funding for a Philadelphia gene engineering startup, and the IPO of an Israeli firm focused on medical applications for lipid-based compounds.
You’ll also notice in these galleries designs not related to any financial transaction. These celebrate a range of awards and employee recognition pieces honoring successful clinical trials, Food and Drug Administration (FDA) and New Drug Application (NDA) submissions, research collaborations and partnerships, and product development milestones.
